Cas:22815-98-1 2-(4-Chlorophenyl)-5-methyl-1,3,4-oxadiazole manufacturer & supplier

We serve Chemical Name:2-(4-Chlorophenyl)-5-methyl-1,3,4-oxadiazole CAS:22815-98-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(4-Chlorophenyl)-5-methyl-1,3,4-oxadiazole

Chemical Name:2-(4-Chlorophenyl)-5-methyl-1,3,4-oxadiazole
CAS.NO:22815-98-1
Synonyms:2-(4-Chlorophenyl)-5-methyl-1,3,4-oxadiazole
Molecular Formula:C9H7ClN2O
Molecular Weight:194.61800
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:38.92000
Exact Mass:194.02500
LogP:2.69840

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-(4-Chlorophenyl)-5-methyl-1,3,4-oxadiazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(4-Chlorophenyl)-5-methyl-1,3,4-oxadiazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(4-Chlorophenyl)-5-methyl-1,3,4-oxadiazole Use and application,2-(4-Chlorophenyl)-5-methyl-1,3,4-oxadiazole technical grade,usp/ep/jp grade.


Related News: As the Covid-19 pandemic continues to challenge the global drug supply chain, nations are looking for new ways to enable native producers to continue scaling up. Now, an Israeli API maker is dropping a down payment into an Indian intermediates company to ramp up its own manufacturing base. rel-(1R,2R)-1-(4-chlorophenyl)-2-(2-nitrophenyl)ethane-1,2-diol manufacturers EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions. 3,3-bis(4-fluorophenyl)allyl (4-((2-hydroxyethyl)carbamoyl)phenyl)carbamate suppliers On top of getting compensated for the past infringements, Plexxikon says it will receive “additional royalty payments for future sales of Tafinlar in the United States through the life of the patents.” Ferredoxin (plasmid pNGR234a clone pXB368 gene fdxB) vendor & factory GBS is a rare but potentially life-threatening disorder in which the body’s immune system attacks nerve cells. The condition has been associated with the use of other widely used vaccines, such as GlaxoSmithKline’s Shingrix. ,EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions.